UK markets closed

PCI Biotech Holding ASA (PCIB.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
1.7480+0.0280 (+1.63%)
At close: 03:18PM CEST
Currency in NOK

Valuation measures4

Market cap (intra-day) 64.20M
Enterprise value 19.20M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.37
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.65

Trading information

Stock price history

Beta (5Y monthly) 1.62
52-week change 3-9.47%
S&P500 52-week change 323.06%
52-week high 33.4000
52-week low 31.2000
50-day moving average 31.7602
200-day moving average 31.9249

Share statistics

Avg vol (3-month) 386.75k
Avg vol (10-day) 337.06k
Shares outstanding 537.33M
Implied shares outstanding 637.33M
Float 829.86M
% held by insiders 123.95%
% held by institutions 18.57%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-370.62%

Management effectiveness

Return on assets (ttm)-25.85%
Return on equity (ttm)-42.13%

Income statement

Revenue (ttm)2.99M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)8.40%
Gross profit (ttm)N/A
EBITDA -21.87M
Net income avi to common (ttm)-20.32M
Diluted EPS (ttm)-0.7900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)41.18M
Total cash per share (mrq)1.1
Total debt (mrq)319k
Total debt/equity (mrq)0.82%
Current ratio (mrq)8.80
Book value per share (mrq)1.05

Cash flow statement

Operating cash flow (ttm)-15.07M
Levered free cash flow (ttm)-8.74M